Marc Grasso was appointed CFO of Kyverna Therapeutics, following his previous roles at Kura Oncology, Morgan Stanley, and UBS.
1 report, 0 independent
Updated Jun 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Marc Grasso was appointed CFO of Kyverna Therapeutics, following his previous roles at Kura Oncology, Morgan Stanley, and UBS.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Kura Oncology
company in La Jolla, United States
Nothing else this week.
-
Ryan Jones
American journalist
Nothing else this week.
Coverage
Newest first; wire copies grouped- Unknown outlet